{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:11:06Z","timestamp":1790518266370,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2017.167","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T13:51:25Z","timestamp":1501595485000},"page":"e1189-e1189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aripiprazole and Riluzole treatment alters behavior and neurometabolites in young ADHD rats: a longitudinal 1H-NMR spectroscopy study at 11.7T"],"prefix":"10.1038","volume":"7","author":[{"given":"F","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Nespoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Fegert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-9795","authenticated-orcid":false,"given":"B","family":"Hengerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Boeckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"BFtp2017167_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mds.20044","volume":"19","author":"DL Gilbert","year":"2004","unstructured":"Gilbert DL, Bansal AS, Sethuraman G, Sallee FR, Zhang J, Lipps T et al. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord 2004; 19: 416\u2013425.","journal-title":"Mov Disord"},{"key":"BFtp2017167_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaac.2010.10.004","volume":"50","author":"CA Mathews","year":"2011","unstructured":"Mathews CA, Grados MA . Familiality of tourette syndrome, obsessive-compulsive disorder, and attention-deficit\/hyperactivity disorder: Heritability analysis in a large sib-pair sample. J Am Acad Child Adolesc Psychiatry 2011; 50: 46\u201354.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFtp2017167_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00787-012-0278-5","volume":"21","author":"ER Lebowitz","year":"2012","unstructured":"Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H et al. Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 2012; 21: 451\u2013457.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"BFtp2017167_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2013\/237513","volume":"27","author":"Mol Debes NMM","year":"2013","unstructured":"Mol Debes NMM. Co-morbid disorders in Tourette syndrome. Behav Neurol Hindawi Publishing Corporation 2013; 27: 7\u201314.","journal-title":"Behav Neurol Hindawi Publishing Corporation"},{"key":"BFtp2017167_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","volume":"72","author":"ME Hirschtritt","year":"2015","unstructured":"Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 2015; 72: 325\u2013333.","journal-title":"JAMA Psychiatry"},{"key":"BFtp2017167_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brs.2013.08.009","volume":"7","author":"T Bunse","year":"2014","unstructured":"Bunse T, Wobrock T, Strube W, Padberg F, Palm U, Falkai P et al. Motor cortical excitability assessed by transcranial magnetic stimulation in psychiatric disorders: a systematic review. Brain Stimul 2014; 7: 158\u2013169.","journal-title":"Brain Stimul"},{"key":"BFtp2017167_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.spen.2005.12.003","volume":"12","author":"G Erenberg","year":"2005","unstructured":"Erenberg G . The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Semin Pediatr Neurol 2005; 12: 217\u2013221.","journal-title":"Semin Pediatr Neurol"},{"key":"BFtp2017167_CR8","first-page":"821","volume":"109","author":"AG Ludolph","year":"2012","unstructured":"Ludolph AG, Roessner V, M\u00fcnchau A, M\u00fcller-Vahl K . Tourette syndrome and other tic disorders in childhood, adolescence and adulthood. Dtsch Arztebl Int 2012; 109: 821\u2013288.","journal-title":"Dtsch Arztebl Int"},{"key":"BFtp2017167_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejpn.2013.01.005","volume":"17","author":"R Rizzo","year":"2013","unstructured":"Rizzo R, Gulisano M, Cal\u00ec PV, Curatolo P . Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. Eur J Paediatr Neurol 2013; 17: 421\u2013428.","journal-title":"Eur J Paediatr Neurol"},{"key":"BFtp2017167_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/B978-0-12-411546-0.00015-9","volume":"112","author":"C Termine","year":"2013","unstructured":"Termine C, Selvini C, Rossi G, Balottin U . Emerging treatment strategies in tourette syndrome: What\u2019s in the pipeline? Int Rev Neurobiol 2013; 112: 445\u2013480.","journal-title":"Int Rev Neurobiol"},{"key":"BFtp2017167_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/2231-4040.177203","volume":"7","author":"P Safavi","year":"2016","unstructured":"Safavi P, Hasanpour-Dehkordi A, AmirAhmadi M . Comparison of risperidone and aripiprazole in the treatment of preschool children with disruptive behavior disorder and attention deficit-hyperactivity disorder: A randomized clinical trial. J Adv Pharm Technol Res 2016; 7: 43\u201347.","journal-title":"J Adv Pharm Technol Res"},{"key":"BFtp2017167_CR12","first-page":"323","volume":"18","author":"A Ghanizadeh","year":"2013","unstructured":"Ghanizadeh A . Systematic review of clinical trials of aripiprazole for treating attention deficit hyperactivity disorder. Neurosciences (Riyadh) 2013; 18: 323\u2013329.","journal-title":"Neurosciences (Riyadh)"},{"key":"BFtp2017167_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/pcn.12394","volume":"70","author":"S Emamzadehfard","year":"2016","unstructured":"Emamzadehfard S, Kamaloo A, Paydary K, Ahmadipour A, Zeinoddini A, Ghaleiha A et al. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive compulsive disorder: randomized, double-blind, placebo-controlled study. Psychiatry Clin Neurosci 2016; 70: 332\u2013341.","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFtp2017167_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.4088\/JCP.14m09123","volume":"76","author":"C Pittenger","year":"2015","unstructured":"Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E et al. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A pilot randomized placebo-controlled trial. J Clin Psychiatry 2015; 76: 1075\u20131084.","journal-title":"J Clin Psychiatry"},{"key":"BFtp2017167_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","volume":"3","author":"C Pittenger","year":"2006","unstructured":"Pittenger C, Krystal JH, Coric V . Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRX 2006; 3: 69\u201381.","journal-title":"NeuroRX"},{"key":"BFtp2017167_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/npp.2013.343","volume":"39","author":"PJ Grant","year":"2014","unstructured":"Grant PJ, Joseph LA, Farmer CA, Luckenbaugh DA, Lougee LC, Zarate CA et al. 12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder. Neuropsychopharmacology 2014; 39: 1453\u20131459.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2017167_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","volume":"58","author":"V Coric","year":"2005","unstructured":"Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005; 58: 424\u2013428.","journal-title":"Biol Psychiatry"},{"key":"BFtp2017167_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pediatrneurol.2015.02.002","volume":"52","author":"ME Lemmon","year":"2015","unstructured":"Lemmon ME, Grados M, Kline T, Thompson CB, Ali SF, Singer HS . Efficacy of glutamate modulators in tic suppression: A double-blind, randomized control trial of D-serine and riluzole in tourette syndrome. Pediatr Neurol 2015; 52: 629\u2013634.","journal-title":"Pediatr Neurol"},{"key":"BFtp2017167_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/CHI.0b013e318185e703","volume":"47","author":"R Marsh","year":"2008","unstructured":"Marsh R, Gerber AJ, Peterson BS . Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry 2008; 47: 1233\u20131251.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFtp2017167_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2015.02.009","volume":"52","author":"J Naaijen","year":"2015","unstructured":"Naaijen J, Lythgoe DJ, Amiri H, Buitelaar JK, Glennon JC . Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: A review of magnetic resonance spectroscopy studies. Neurosci Biobehav Rev 2015; 52: 74\u201388.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp2017167_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.4155\/bio.12.129","volume":"4","author":"MR Lee","year":"2012","unstructured":"Lee MR, Denic A, Hinton DJ, Mishra PK, Choi D-S, Pirko I et al. Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis 2012; 4: 1787\u20131804.","journal-title":"Bioanalysis"},{"key":"BFtp2017167_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.neuropharm.2009.08.004","volume":"57","author":"T Sagvolden","year":"2009","unstructured":"Sagvolden T, Johansen EB, W\u00f8ien G, Walaas SI, Storm-Mathisen J, Bergersen LH et al. The spontaneously hypertensive rat model of ADHD\u2013the importance of selecting the appropriate reference strain. Neuropharmacology 2009; 57: 619\u2013626.","journal-title":"Neuropharmacology"},{"key":"BFtp2017167_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/nbm.1940020504","volume":"2","author":"J Frahm","year":"1989","unstructured":"Frahm J, Michaelis T, Merboldt KD, H\u00e4nicke W, Gyngell ML, Chien D et al. Localized NMR spectroscopy in vivo. Progress and problems. NMR Biomed 1989; 2: 188\u2013195.","journal-title":"NMR Biomed"},{"key":"BFtp2017167_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0014-4886(71)90009-4","volume":"32","author":"SW De Souza","year":"1971","unstructured":"De Souza SW, Dobbing J . Cerebral edema in developing brain. I. Normal water and cation content in developing rat brain and postmortem changes. Exp Neurol 1971; 32: 431\u2013438.","journal-title":"Exp Neurol"},{"key":"BFtp2017167_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0163-1047(79)91801-6","volume":"27","author":"S Knardahl","year":"1979","unstructured":"Knardahl S, Sagvolden T . Open-field behavior of spontaneously hypertensive rats. Behav Neural Biol 1979; 27: 187\u2013200.","journal-title":"Behav Neural Biol"},{"key":"BFtp2017167_CR26","doi-asserted-by":"publisher","first-page":"e12959","DOI":"10.1371\/journal.pone.0012959","volume":"5","author":"Y Worbe","year":"2010","unstructured":"Worbe Y, Mallet L, Golmard J-L, B\u00e9har C, Durif F, Jalenques I et al. Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PLoS One 2010; 5: e12959.","journal-title":"PLoS One"},{"key":"BFtp2017167_CR27","first-page":"624","volume":"4","author":"P Sengupta","year":"2013","unstructured":"Sengupta P . The laboratory rat: relating its age with human\u2019s. Int J Prev Med 2013; 4: 624\u2013630.","journal-title":"Int J Prev Med"},{"key":"BFtp2017167_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000360859","volume":"69","author":"C Hoyer","year":"2014","unstructured":"Hoyer C, Gass N, Weber-Fahr W, Sartorius A . Advantages and challenges of small animal magnetic resonance imaging as a translational tool. Neuropsychobiology 2014; 69: 187\u2013201.","journal-title":"Neuropsychobiology"},{"key":"BFtp2017167_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/nbm.3095","volume":"27","author":"SV Liubinas","year":"2014","unstructured":"Liubinas SV, Drummond KJ, Desmond PM, Bjorksten A, Morokoff AP, Kaye AH et al. Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging. NMR Biomed 2014; 27: 570\u2013577.","journal-title":"NMR Biomed"},{"key":"BFtp2017167_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mrm.1910320202","volume":"32","author":"PB Barker","year":"1994","unstructured":"Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994; 32: 157\u2013163.","journal-title":"Magn Reson Med"},{"key":"BFtp2017167_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/BF00965747","volume":"15","author":"R Burri","year":"1990","unstructured":"Burri R, Bigler P, Straehl P, Posse S, Colombo JP, Herschkowitz N . Brain development: 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods. Neurochem Res 1990; 15: 1009\u20131016.","journal-title":"Neurochem Res"},{"key":"BFtp2017167_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1023\/A:1010947605921","volume":"26","author":"J Battistuta","year":"2001","unstructured":"Battistuta J, Bjartmar C, Trapp BD . Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions. Neurochem Res 2001; 26: 695\u2013702.","journal-title":"Neurochem Res"},{"key":"BFtp2017167_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.psychres.2009.08.008","volume":"179","author":"J-W Hsu","year":"2010","unstructured":"Hsu J-W, Lee L-C, Chen R-F, Yen C-T, Chen Y-S, Tsai M-L . Striatal volume changes in a rat model of childhood attention-deficit\/hyperactivity disorder. Psychiatry Res 2010; 179: 338\u2013341.","journal-title":"Psychiatry Res"},{"key":"BFtp2017167_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","volume":"68","author":"B-C Ho","year":"2011","unstructured":"Ho B-C, Andreasen NC, Ziebell S, Pierson R, Magnotta V . Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128\u2013137.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2017167_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/7854_2011_121","volume":"9","author":"X Fan","year":"2011","unstructured":"Fan X, Bruno KJ, Hess EJ . Rodent models of ADHD. Curr Top Behav Neurosci 2011; 9: 273\u2013300.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFtp2017167_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4236\/jbbs.2012.23036","volume":"2","author":"R Alves","year":"2012","unstructured":"Alves R, Barbosa De Carvalho G, Antonio M, Venditti C . High-and low-rearing rats differ in the brain excitability controlled by the allosteric benzodiazepine site in the GABA A receptor. J Behav Brain Sci 2012; 2: 315\u2013325.","journal-title":"J Behav Brain Sci"},{"key":"BFtp2017167_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0006-3223(02)01401-4","volume":"53","author":"FP MacMaster","year":"2003","unstructured":"MacMaster FP, Carrey N, Sparkes S, Kusumakar V . Proton spectroscopy in medication-free pediatric attention-deficit\/hyperactivity disorder. Biol Psychiatry 2003; 53: 184\u2013187.","journal-title":"Biol Psychiatry"},{"key":"BFtp2017167_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1176\/jnp.16.1.63","volume":"16","author":"H Courvoisie","year":"2004","unstructured":"Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M . Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004; 16: 63\u201369.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"BFtp2017167_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/cap.2006.0008","volume":"17","author":"N Carrey","year":"2007","unstructured":"Carrey N, MacMaster F, Gaudet L, Schmidt M . Striatal creatine and glutamate\/glutamine in attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17: 11\u201317.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BFtp2017167_CR40","first-page":"635","volume":"115","author":"V Husarova","year":"2014","unstructured":"Husarova V, Bittsansky M, Ondrejka I, Dobrota D . Correlations of ADHD symptoms with neurometabolites measured by 1H magnetic resonance spectroscopy. Bratisl Lek Listy 2014; 115: 635\u2013642.","journal-title":"Bratisl Lek Listy"},{"key":"BFtp2017167_CR41","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1021\/pr800892u","volume":"8","author":"GA McLoughlin","year":"2009","unstructured":"McLoughlin GA, Ma D, Tsang TM, Jones DNC, Cilia J, Hill MD et al. Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. J Proteome Res 2009; 8: 1943\u20131952.","journal-title":"J Proteome Res"},{"key":"BFtp2017167_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/NDT.S52338","volume":"10","author":"L Benamor","year":"2014","unstructured":"Benamor L . (1)H-Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder. Neuropsychiatr Dis Treat 2014; 10: 47\u201354.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtp2017167_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pscychresns.2014.03.003","volume":"222","author":"V Husarova","year":"2014","unstructured":"Husarova V, Bittsansky M, Ondrejka I, Dobrota D . Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit\/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study. Psychiatry Res 2014; 222: 75\u201383.","journal-title":"Psychiatry Res"},{"key":"BFtp2017167_CR44","first-page":"90","volume":"21","author":"AS Kanaan","year":"2016","unstructured":"Kanaan AS, Gerasch S, Garc\u00eda-Garc\u00eda I, Lampe L, Pampel A, Anwander A et al. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain 2016; 21: 90\u201397.","journal-title":"Brain"},{"key":"BFtp2017167_CR45","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1038\/npp.2014.79","volume":"39","author":"CF Waschkies","year":"2014","unstructured":"Waschkies CF, Bruns A, M\u00fcller S, Kapps M, Borroni E, von Kienlin M et al. Neuropharmacological and neurobiological relevance of in vivo1H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders. Neuropsychopharmacology 2014; 39: 2331\u20132339.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2017167_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pscychresns.2014.02.004","volume":"222","author":"AM Weber","year":"2014","unstructured":"Weber AM, Soreni N, Stanley JA, Greco A, Mendlowitz S, Szatmari P et al. Proton magnetic resonance spectroscopy of prefrontal white matter in psychotropic na\u00efve children and adolescents with obsessive\u2013compulsive disorder. Psychiatry Res Neuroimaging 2014; 222: 67\u201374.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"BFtp2017167_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bpsc.2015.12.003","volume":"1","author":"BP Brennan","year":"2016","unstructured":"Brennan BP, Jensen JE, Perriello C, Pope HG, Jenike MA, Hudson JI et al. Lowerposterior cingulate cortex glutathione levels in obsessive compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2016; 1: 116\u2013124.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2017167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017167","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:03:41Z","timestamp":1671728621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2017167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"alternative-id":["BFtp2017167"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.167","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]},"assertion":[{"value":"20 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the last 5 years Professor JMF received research funding from the EU, DFG (German Research Foundation), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), German armed forces, several state ministries of social affairs, State Foundation Baden-W\u00fcrttemberg, Volkswagen Foundation, European Academy, Pontifical Gregorian University, RAZ, CJD, Caritas, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from DFG, AACAP, NIMH\/NIH, EU, Pro Helvetia, Shire, several universities, professional associations, political foundations, and German federal and state ministries. Clinical trials for Lundbeck, BMBF, Servier. Professor Fegert holds no stocks of pharmaceutical companies. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}